Livongo Health Q3 Adj. EPS $0.16 Beats $0.05 Estimate, Sales $106.10M Beat $98.80M Estimate
Livongo Health Q3 Adj. EPS $0.16 Beats $0.05 Estimate, Sales $106.10M Beat $98.80M Estimate
Livongo Health第三季度调整后每股收益0.16美元超过预期0.05美元，销售额1.061亿美元超过预期9880万美元
Livongo Health (NASDAQ:LVGO) reported quarterly earnings of $0.16 per share which beat the analyst consensus estimate of $0.05 by 220 percent. This is a 420 percent increase over losses of $(0.05) per share from the same period last year. The company reported quarterly sales of $106.10 million which beat the analyst consensus estimate of $98.80 million by 7.39 percent. This is a 127.40 percent increase over sales of $46.66 million the same period last year.
Livongo Health(纳斯达克：LVGO)公布的季度收益为每股0.16美元，比分析师普遍预期的0.05美元高出220%。这比去年同期每股亏损0.05美元增加了420%。该公司公布的季度销售额为1.061亿美元，比分析师普遍预期的9880万美元高出7.39%。这比去年同期4,666万美元的销售额增长了127.40%。